Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a32ecaf22697489ea2a19e63f844d596 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c9242c59b7c4ad5f682c51b5fd62380 |
publicationDate |
2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2012244210-A1 |
titleOfInvention |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
abstract |
The present invention concerns methods and compositions for the treatment of cancer and cancer cells using intravascular administration of a vaccinia virus. In some embodiments, methods and compositions involve a replicative vaccinia virus that encodes GM-CSF. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105658795-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2014308648-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-037582-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478518-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015027163-A1 |
priorityDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |